The European Vaccine Initiative (EVI) is a non-profit Product Development Partnership supporting the development of vaccines for diseases of poverty by bridging conceptual and operational gaps in translational research. EVI supports the strengthening of the vaccine R&D infrastructure in Europe, harmonisation, knowledge sharing and aligning of major vaccine R&D stakeholders. Areas of EVI's expertise in vaccine development from preclinical to clinical proof-of-concept include process development, development of quality control assays, optimisation of GMP production, selection of the most appropriate delivery system, development of formulation with adjuvants and early stage clinical development. EVI has extensive experience of more than a decade in coordinating in large scale infrastructure and collaborative research projects funded by the EC and other funding agencies during the last decade.
Role of EVI in VAC2VAC
EVI is the project coordinator of VAC2VAC and is in charge of administrative-financial management, dissemination and communication. Moreover, EVI will contribute to the development, dissemination and implementation of Standard Operating Procedures (SOPs) for key assays; contribute to development and reference preparations and common reagents, contribute to the harmonisation and standardisation of methods and assays. Additionally, EVI will also contribute to the preparation of a roadmap and engagement of regulatory bodies.